Neisseria gonorrhoeae MS11mkC opacity protein expression in vitro and during human volunteer infectivity studies

Sexually Transmitted Diseases

Volumn 27, Issue 5, 2000, Pages 278-283

  Schmidt, Katherine A ^a,d   Deal, Carolyn D ^b   Kwan, Matthew ^c   Thattassery, Emil ^c   Schneider, Herman ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; OPACITY PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL ARTICLE; GONORRHEA; HUMAN; IMMUNOBLOTTING; MALE; NEISSERIA GONORRHOEAE; PROTEIN EXPRESSION;

EID: 0034065166     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007435-200005000-00008     Document Type: Article

References (40)

1. Dekker NP, Lammel CJ, Mandrell RE, Brooks GF. Opa (protein II) influences gonococcal organization in colonies, surface appearance, size and attachment to human fallopian tube epithelium. Microbial Path 1990; 9:19-31.
2. Elkins C, Rest RF. Monoclonal antibodies to outer membrane protein PII block interactions of Neisseria gonorrhoeae with human neutrophils. Infect Immun 1990; 58:1078-1084.
3. Fischer SH, Rest RF. Gonococci possessing only certain P.II outer membrane proteins interact with human neutrophils. Infect Immun 1988; 56:1574-1579.
4. Meyer TF, Pohlner J, van Putten JPM. Biology of the pathogenic Neisseriae. In: Dangl JL, ed. Bacterial Pathogenesis of Plants and Animals: Molecular and Cellular Mechanisms. Vol 192. Berlin: Springer Verlag, 1994:283-317.
5. Bhat KS, Gibbs CP, Barrera O, et al. The opacity proteins of Neisseria gonorrhoeae strain MS11 are encoded by a family of 11 complete genes. Molec Microbiol 1991; 5:1189-1901.
6. Kupsch E-M, Knepper B, Kuroki T, Heuer I, Meyer TF. Variable opacity (Opa) outer membrane proteins account for the cell tropisms displayed by Neisseria gonorrhoeae for human leukocytes and epithelial cells. EMBO J 1993; 12:641-650.
7. Naids FL, Belisle B, Lee N, Rest R. Interactions of Neisseria gonorrhoeae with human neutrophils: studies with purified PII (Opa) outer membrane proteins and synthetic Opa peptides. Infect Immun 1991; 59:4628-4635.
8. Makino S-I, van Putten JPM, Meyer TF. Phase variation of the opacity outer membrane protein controls invasion by Neisseria gonorrhoeae into human epithelial cells. EMBO J 1991; 10:1307-1315.
9. Robinson EN, Clemens CM, McGee ZA, Cannon JG. Immunoelectron microscope localization of outer membrane proteins II on the surface of Neisseria gonorrhoeae. Infect Immun 1988; 56:1003-1006.
10. Stern A, Nickel P, Meyer TF, So M. Opacity determinants of Neisseria gonorrhoeae: gene expression and chromosomal linkage to the gonococcal pilus gene. Cell 1984; 37:447-456.
11. Sparling PF, Cannon JG, So M. Phase and antigenic variation of pili and outer membrane protein II of Neisseria gonorrhoeae. J Infect Dis 1986; 153:196-201.
12. Beiland RJ, Morrison SG, van der Ley P, Swanson J. Expression and phase variation of gonococcal P.II genes in Escherichia coli involves ribosomal frameshifting and slipped-strand mispairing. Mol Microbiol 1989; 3:777-786.
13. Black WJ, Schwalbe RS, Nachamkin I, Cannon JG. Characterization of Neisseria gonorrhoeae Protein II phase variation by use of monoclonal antibodies. Infect Immun 1984; 45:453-457.
14. Swanson J. Colony opacity and Protein II compositions of gonococci. Infect Immun 1982; 37:359-368.
15. Meyer TF, van Putten JPM. Genetic mechanisms and biological implications of phase variation in pathogenic Neisseriae. Clin Microbiol Rev 1989; 2:S139-S145.
16. Murphy GL, Connell TD, Barritt DS, Koomey M, Cannon JG. Phase variation of gonococcal Protein II: regulation of gene expression by slipped-strand mispairing of a repetitive DNA sequence. Cell 1989; 56:539-547.
17. Stern A, Brown M, Nickel P, Meyer T. Opacity genes in Neisseria gonorrhoeae: control of phase and antigenic variation. Cell 1986; 47:61-71.
18. Levinson G, Gutman GA. High frequencies of short frameshifts in poly-CA/TG tandem repeats borne by bacteriophage M13 in Escherichia coli K-12. Nucleic Acid Res 1987; 15:5323-5338.
19. Mayer LW. Rates of in vitro changes of gonococcal colony opacity phenotypes. Infect Immun 1982; 37:481-485.
20. Swanson J, Barrera O, Sola J, Boslego J. Expression of outer membrane protein II by gonococci in experimental gonorrhea. J Exp Med 1988; 168:2121-2129.
21. Schneider H, Cross AS, Kuschner RA, et al. Experimental human gonococcal urethritis: 250 Neisseria gonorrhoeae MS11mkC are infectious. J Infect Dis 1995; 172:180-185.
22. Schneider H, Schmidt KA, Skillman DR, et al. Sialylation lessens the infectivity of Neisseria gonorrhoeae MS11mkC. J Infect Dis 1996; 173:1422-1427.
23. Schneider H, Griffiss JM, Boslego JW, Hitchcock PJ, Zahos KM, Apicella MA. Expression of paragloboside-like lipooligosaccharides may be a necessary component of gonococcal pathogenesis in men. J Exp Med 1991; 174:1601-1605.
24. Blake MS, Gotschlich EC. Purification and partial characterization of the opacity-associated proteins of Neisseria gonorrhoeae. J Exp Med 1984; 159:452-462.
25. Lowry OH, Rosebrough NJ, Fair AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193:265-276.
26. Jerse AE, Cohen MS, Drown PM, et al. Multiple gonococcal opacity proteins are expressed during experimental urethral infection in the male. J Exp Med 1994; 179:911-920.
27. Laemmli UK. Cleavage of structural proteins during the assembly of the head of the bacteriophage T4. Nature 1970; 227:680-685.
28. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A 1979; 76:4350-4354.
29. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989.
30. Achtman M, Neibert M, Crowe BA, et al. Purification and characterization of eight class 5 outer membrane protein variants from a clone of Neisseria meningitidis serogroup A. J Exp Med 1988; 168:507-525.
31. Blake MS, Blake CM, Apicella MA, Mandrell RE. Gonococcal opacity: lectin-like interactions between Opa proteins and lipooligosaccharide. Infect Immun 1995; 63:1434-1439.
32. Freund JE, Smith RM. Statistics: a first Course. 4th ed. Englewood Cliffs, NJ: Prentice-Hall Inc., 1986.
33. + gonococci to epithelial cells in vitro involves heparin sulfate. J Exp Med 1995; 182:511-517.
34. Gray-Owen SD, Lorenzen DR, Haude A, Meyer TF, Dehio C. Differential Opa specificities for CD66 receptors influence tissue interactions and cellular response to Neisseria gonorrhoeae. Mol Microbiol 1997; 26:971-980.
35. Bos MP, Grunert F, Belland RJ. Differential recognition of members of the carcinoembryonic antigen family by Opa variants of Neisseria gonorrhoeae. Infect Immun 1997; 65:2353-2361.
36. Grassmé HUC, Ireland RM, van Putten JPM. Gonococcal opacity protein promotes bacterial entry-associated rearrangements of the epithelial cell actin cytoskeleton. Infect Immun 1996; 64:1621-1630.
37. Weel JFL, Hopman CTP, van Putten JPM. In situ expression and localization of Neisseria gonorrhoeae opacity proteins in infected epithelial cells: apparent role of Opa proteins in cellular invasion. J Exp Med 1991; 173:1395-1405.
38. Cheung AL, Nast CC, Bayer AS. Selective activation of sar promoters with the use of green fluorescent protein transcriptional fusions as the detection system in the rabbit endocarditis model. Infect Immun 1998; 66:5988-5993.
39. Miller JF, Mekalanos JJ, Falkow S. Coordinate regulation and sensory transduction in the control of bacterial virulence. Science 1989; 243:916-922.
40. Belland RJ, Morrison SG, Carlson JH, Hogan DM. Promoter strength influences phase variation of neisserial opa genes. Mol Microbiol 1997; 23:123-135.